BridgeBio's Approach to Gene Therapy & Nearing the Clinic

Cell & Gene: The Podcast

English - October 14, 2021 08:00 - 24 minutes - 16.9 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Inside Spark Therapeutics' Investigational SPK-8011 for Hemophilia A

Next Episode: Advancing Patient Engagement with Novartis Gene Therapies' Dr. Amy Nicole Nayar

BridgeBio's CEO of Gene Therapy, Dr. Eric David, explains the company's gene therapy programs for Canavan disease and congenital adrenal hyperplasia, their manufacturing plans, and the platform underpinning their novel approach to gene therapy.